BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32567593)

  • 21. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of rectal carcinoma at 3.0T: Image quality and histological T staging.
    Peng Y; Li Z; Tang H; Wang Y; Hu X; Shen Y; Hu D
    J Magn Reson Imaging; 2018 Apr; 47(4):967-975. PubMed ID: 28691219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
    van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
    Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI evaluation of extramural vascular invasion by inexperienced radiologists.
    Wang S; Li XT; Zhang XY; Sun RJ; Qu YH; Zhu HC; Guan Z; Sun YS
    Br J Radiol; 2019 Dec; 92(1104):20181055. PubMed ID: 31596129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging.
    Liu S; Wen L; Hou J; Nie S; Zhou J; Cao F; Lu Q; Qin Y; Fu Y; Yu X
    Abdom Radiol (NY); 2019 Aug; 44(8):2689-2698. PubMed ID: 31030244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.
    Ippolito D; Drago SG; Franzesi CT; Fior D; Sironi S
    World J Gastroenterol; 2016 May; 22(20):4891-900. PubMed ID: 27239115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
    Sassen S; de Booij M; Sosef M; Berendsen R; Lammering G; Clarijs R; Bakker M; Beets-Tan R; Warmerdam F; Vliegen R
    Eur Radiol; 2013 Dec; 23(12):3440-9. PubMed ID: 23832319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
    Jang JK; Lee CM; Park SH; Kim JH; Kim J; Lim SB; Yu CS; Kim JC
    Korean J Radiol; 2021 Sep; 22(9):1451-1461. PubMed ID: 34132075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
    Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
    Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.
    Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F
    Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy.
    Ha HI; Kim AY; Yu CS; Park SH; Ha HK
    Eur Radiol; 2013 Dec; 23(12):3345-53. PubMed ID: 23812242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
    Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
    Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.